Bactrim: Potent Dual-Antibiotic Therapy for Bacterial Infections
| Product dosage: 480mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.39 | $35.26 (0%) | 🛒 Add to cart |
| 120 | $0.36 | $47.01 $43.00 (9%) | 🛒 Add to cart |
| 180 | $0.32 | $70.52 $58.48 (17%) | 🛒 Add to cart |
| 270 | $0.31 | $105.78 $83.42 (21%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $141.04 $104.06 (26%) | 🛒 Add to cart |
Bactrim is a combination antibiotic medication containing sulfamethoxazole and trimethoprim, designed to provide synergistic bactericidal action against a wide spectrum of susceptible bacteria. This fixed-dose combination leverages two antimicrobial agents working sequentially on bacterial folate synthesis, effectively inhibiting growth and proliferation of pathogenic organisms. It remains a clinically relevant choice for treating various infections, from urinary tract infections to certain opportunistic infections in immunocompromised patients, particularly when resistance patterns or clinical scenarios warrant its use.
Features
- Contains sulfamethoxazole 400 mg and trimethoprim 80 mg per tablet
- Dual-mechanism action targeting bacterial dihydrofolate reductase and dihydropteroate synthase
- Available in oral tablet and liquid suspension formulations
- Demonstrated efficacy against both gram-positive and gram-negative organisms
- Standardized dosing based on trimethoprim component
- Manufactured under strict pharmaceutical quality controls
Benefits
- Provides broad-spectrum coverage against common pathogenic bacteria
- Synergistic antibacterial effect enhances potency and reduces development of resistance
- Effective treatment for recurrent or resistant urinary tract infections
- Proven efficacy in managing Pneumocystis jirovecii pneumonia prophylaxis and treatment
- Useful alternative for patients with penicillin allergies in appropriate clinical scenarios
- Established safety profile with decades of clinical use and monitoring
Common use
Bactrim is commonly prescribed for the treatment of urinary tract infections, including cystitis and pyelonephritis, caused by susceptible strains of Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis, and Proteus vulgaris. It is also indicated for acute exacerbations of chronic bronchitis in adults due to susceptible strains of Haemophilus influenzae and Streptococcus pneumoniae when in the judgment of the physician. Additionally, Bactrim is used for the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated. In immunocompromised patients, particularly those with HIV/AIDS, it serves as both prophylaxis and treatment for Pneumocystis jirovecii pneumonia. Off-label uses may include treatment of certain skin and soft tissue infections, otitis media, sinusitis, and traveler’s diarrhea when caused by susceptible organisms.
Dosage and direction
For the treatment of urinary tract infections and shigellosis in adults and children, and for acute exacerbations of chronic bronchitis in adults: The usual adult dosage is 1 DS tablet (double strength) or 2 regular tablets every 12 hours for 10 to 14 days. For children, the recommended dose is 8 mg/kg trimethoprim and 40 mg/kg sulfamethoxazole per 24 hours, given in two divided doses every 12 hours for 10 days.
For Pneumocystis jirovecii pneumonia treatment: The recommended dosage is 15-20 mg/kg trimethoprim and 75-100 mg/kg sulfamethoxazole per 24 hours given in equally divided doses every 6 hours for 14 to 21 days.
For Pneumocystis jirovecii pneumonia prophylaxis: The recommended dosage is 1 DS tablet daily or 3 times per week on consecutive days (e.g., Monday, Tuesday, Wednesday).
All doses should be taken with a full glass of water and patients should maintain adequate fluid intake to prevent crystalluria and stone formation. The medication is best absorbed when taken with food to minimize gastrointestinal upset.
Precautions
Patients should be advised to complete the full course of therapy even if they feel better, as premature discontinuation may result in incomplete eradication of microorganisms and lead to recurrence of infection and potential development of resistance. Regular monitoring of complete blood counts is recommended during prolonged therapy, as hematologic changes may occur. Patients with impaired renal or hepatic function, severe allergy or bronchial asthma, glucose-6-phosphate dehydrogenase deficiency, or folate deficiency require careful monitoring and possible dosage adjustment. Sun exposure should be limited during therapy, as photosensitivity reactions may occur. Elderly patients may be more susceptible to adverse effects, particularly hyperkalemia and bone marrow suppression. Regular assessment of renal function and electrolyte levels is advised during treatment, especially in patients with pre-existing renal impairment or those taking concomitant medications that affect potassium excretion.
Contraindications
Bactrim is contraindicated in patients with documented hypersensitivity to trimethoprim, sulfonamides, or any component of the formulation. It should not be used in patients with megaloblastic anemia due to folate deficiency. Contraindications include marked hepatic damage, severe renal insufficiency when renal function cannot be monitored, and infants less than 2 months of age due to the risk of kernicterus. The medication is also contraindicated in pregnancy at term and during the nursing period because sulfonamides may displace bilirubin from protein binding sites in the newborn infant. Patients with history of drug-induced immune thrombocytopenia with sulfonamides or trimethoprim should not receive Bactrim.
Possible side effect
Common adverse reactions include nausea, vomiting, loss of appetite, and gastrointestinal distress. Dermatological reactions such as rash, pruritus, and photosensitivity may occur. Hematologic effects including leukopenia, neutropenia, thrombocytopenia, agranulocytosis, aplastic anemia, and megaloblastic anemia have been reported. Hyperkalemia is a particular concern, especially in elderly patients or those with renal impairment. Allergic reactions ranging from mild rash to Stevens-Johnson syndrome and toxic epidermal necrolysis, though rare, represent serious potential complications. Other reported side effects include hepatitis, elevated liver enzymes, pseudomembranous colitis, headache, depression, hallucinations, and crystalluria with possible kidney stone formation. Serum sickness-like reactions, drug fever, and anaphylactic reactions have been documented in some patients.
Drug interaction
Bactrim may potentiate the effects of warfarin and other oral anticoagulants, requiring close monitoring of prothrombin time. It may enhance the hypoglycemic effects of sulfonylurea drugs. Concurrent use with angiotensin-converting enzyme inhibitors or potassium-sparing diuretics may increase the risk of hyperkalemia. Bactrim may increase concentrations of phenytoin, necessitating monitoring of phenytoin levels. Methotrexate levels may be increased, enhancing its toxic effects. The medication may decrease the efficacy of oral contraceptives; alternative contraceptive methods should be considered during therapy. Cyclosporine levels may be increased with concomitant use, requiring dosage adjustment. Thiazide diuretics may increase the risk of thrombocytopenia in elderly patients. Bactrim may interfere with the urinary excretion of amantadine.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed dose. Maintaining consistent blood levels is important for antibacterial efficacy, so patients should strive to take doses at evenly spaced intervals. If multiple doses are missed or there is uncertainty about what to do, patients should consult their healthcare provider for guidance.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, headache, mental depression, confusion, and bone marrow depression. Massive overdose may result in jaundice, crystalluria, hematuria, and other blood dyscrasias. In case of suspected overdose, immediate medical attention should be sought. Treatment is supportive and symptomatic. If ingestion is recent, gastric lavage may be indicated. forced diuresis and urinary acidification may enhance renal elimination. Peritoneal dialysis is not effective, and hemodialysis is only moderately effective in removing trimethoprim and sulfamethoxazole. Blood counts should be monitored, and specific attention should be given to potential electrolyte abnormalities, particularly hyperkalemia.
Storage
Bactrim tablets should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F) in a tightly closed container, protected from light and moisture. The oral suspension should be stored at room temperature and discarded after 35 days if unused. All medications should be kept out of reach of children and pets. Do not store in bathroom areas where moisture could affect stability. Do not use after the expiration date printed on the packaging. Proper disposal of unused medication should follow local guidelines for pharmaceutical waste.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read in this product information. The manufacturer and distributors do not assume any liability for inaccuracies or omissions in this information.
Reviews
Clinical studies have demonstrated Bactrim’s efficacy in multiple indications, with success rates of 85-95% in uncomplicated urinary tract infections caused by susceptible organisms. In Pneumocystis jirovecii pneumonia prophylaxis, it has shown superior efficacy compared to alternative regimens, reducing incidence by 90-95% in high-risk populations. However, increasing resistance patterns, particularly among Escherichia coli strains in some regions, have impacted its empirical use for urinary tract infections. Many clinicians appreciate its cost-effectiveness and broad spectrum, though monitoring requirements and potential side effects necessitate careful patient selection. Patient satisfaction varies, with some reporting excellent results while others experience gastrointestinal side effects or allergic reactions. The drug maintains its position in treatment guidelines for specific indications despite the development of newer antibiotics.